Global Cell Therapy Biomanufacturing Market Report By Product Type (Type of Therapy, Source of Cells, Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy), By Application (Cardiovascular Disease, Microparticles Cell Imitation, Bone Repair, Neurological Disorders, Spinal Cord Injury, Stroke, Parkinson’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Cerebral Palsy, Alzheimer's Disease, Vision Restoration, Vertebral Repair, Batten's Disease, Skeletal Muscle Repair, Intrinsic Healing Mechanisms, Cell Therapy Mechanism, Cancer, Other Diseases) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Cell Therapy Biomanufacturing Market Report
Brand: Value Market Research
SKU: Biotechnology
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11217150

December 2022

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Cell Therapy Biomanufacturing Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Cell therapy biomanufacturing begins with the collection of cells from a patient in a clinical facility and ends with the patient receiving the final therapeutic product at the bedside. There are dozens of hand-off sites and activities between the beginning collecting of raw materials and the final administration of a product. Cell-based therapy biomanufacturing strategies differ significantly from conventional models best suited for non-cellular medicines and traditional biologics.

Market Dynamics

The cell therapy biomanufacturing industry is expected to expand due to a growing emphasis on customized medicine and a rise in public-private partnerships to develop cell treatments. The rising prevalence of cardiovascular diseases, increased demand for chimeric antigen receptor (CAR) T cell therapy, and the continuous development of stem cell therapy technologies are driving the cell therapy biomanufacturing market. Customers and other stakeholders are working with biomanufacturing businesses to enhance clinical research and commercial production of these medications. As a result, the cell therapy biomanufacturing industry is predicted to expand. However, manufacturer bottlenecks during cell therapy commercialization, high costs associated with cell therapies, and a lack of competent employees to operate complex instruments impede the expansion of the cell therapy biomanufacturing market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell therapy biomanufacturing. The growth and trends of cell therapy biomanufacturing industry provide a holistic approach to this study.

Market Segmentation

This section of the cell therapy biomanufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Type Of Therapy
Source Of Cells
Rise In The Demand For Chimeric Antigen Receptor (Car) T Cell Therapy

By Application

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Cell Therapy Biomanufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Cell Therapy Biomanufacturing Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell therapy biomanufacturing market include Bone Therapeutics Sa, Bristol-Myers Squibb Co., Caladrius Biosciences Inc., Cell Therapies Pty Ltd., Cellular Biomedicine Group Inc., Iovance Biotherapeutics Inc., Lonza Group Ltd., Merck Kgaa, Neurogeneration Inc., Novartis Ag, Regen Biopharma Inc., Regeneus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3 . CELL THERAPY BIOMANUFACTURING – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product Type
           3.7.2 By Application
           3.7.3 By Region

4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CELL THERAPY BIOMANUFACTURING MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Product Type
       6.4 Type of Therapy Market by Regions
       6.6 Source of Cells Market by Regions
       6.5 Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy Market by Regions

7 . GLOBAL CELL THERAPY BIOMANUFACTURING MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Cardiovascular Disease Market by Regions
       7.5 Microparticles Cell Imitation Market by Regions
       7.6 Bone Repair Market by Regions
       7.7 Neurological Disorders Market by Regions
       7.8 Spinal Cord Injury Market by Regions
       7.9 Stroke Market by Regions
       7.10. Parkinson’s Disease Market by Regions
       7.11 Amyotrophic Lateral Sclerosis Market by Regions
       7.12 Multiple Sclerosis Market by Regions
       7.13 Cerebral Palsy Market by Regions
       7.14 Alzheimer's Disease Market by Regions

8 . GLOBAL CELL THERAPY BIOMANUFACTURING MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE CELL THERAPY BIOMANUFACTURING COMPANIES
       9.1. Cell Therapy Biomanufacturing Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF CELL THERAPY BIOMANUFACTURING INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Bone Therapeutics Sa
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bristol-Myers Squibb Co.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Caladrius Biosciences Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Cell Therapies Pty Ltd.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Cellular Biomedicine Group Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Iovance Biotherapeutics Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Lonza Group Ltd.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Merck Kgaa
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Neurogeneration Inc.
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Novartis Ag
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Regen Biopharma Inc.
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. Regeneus Ltd.
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Cell Therapy Biomanufacturing Report
Market Research Process
Market Research Methodology
Global Cell Therapy Biomanufacturing Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product Type (USD MN)
Type of Therapy Market by Geography (USD MN)
Source of Cells Market by Geography (USD MN)
Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy Market by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Cardiovascular Disease Market by Geography (USD MN)
Microparticles Cell Imitation Market by Geography (USD MN)
Bone Repair Market by Geography (USD MN)
Neurological Disorders Market by Geography (USD MN)
Spinal Cord Injury Market by Geography (USD MN)
Stroke Market by Geography (USD MN)
Parkinson’s Disease Market by Geography (USD MN)
Amyotrophic Lateral Sclerosis Market by Geography (USD MN)
Multiple Sclerosis Market by Geography (USD MN)
Cerebral Palsy Market by Geography (USD MN)
Alzheimer's Disease Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

Market Dynamics

Market Segmentation

Regional Analysis